Short Interest in Relx Plc (NYSE:RELX) Grows By 34.7%

Relx Plc (NYSE:RELX - Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,630,000 shares, an increase of 34.7% from the April 30th total of 1,210,000 shares. Based on an average daily volume of 749,900 shares, the short-interest ratio is presently 2.2 days. Currently, 0.1% of the company's shares are short sold.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Modern Wealth Management LLC bought a new position in shares of Relx during the 1st quarter worth about $278,000. Rhumbline Advisers grew its stake in Relx by 1.2% in the first quarter. Rhumbline Advisers now owns 34,906 shares of the technology company's stock valued at $1,760,000 after acquiring an additional 411 shares during the period. Advisors Capital Management LLC increased its holdings in shares of Relx by 1.3% during the first quarter. Advisors Capital Management LLC now owns 146,691 shares of the technology company's stock valued at $7,395,000 after acquiring an additional 1,867 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Relx by 60.2% during the first quarter. Acadian Asset Management LLC now owns 14,302 shares of the technology company's stock worth $720,000 after purchasing an additional 5,374 shares during the period. Finally, Geneos Wealth Management Inc. grew its position in Relx by 52.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 3,732 shares of the technology company's stock valued at $188,000 after purchasing an additional 1,277 shares during the period. 15.02% of the stock is owned by institutional investors.

Relx Trading Down 1.1%

Shares of Relx stock traded down $0.61 on Thursday, reaching $53.75. 2,057,397 shares of the company's stock were exchanged, compared to its average volume of 738,438. The company has a market capitalization of $99.23 billion, a P/E ratio of 28.90, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. Relx has a 52 week low of $43.45 and a 52 week high of $56.33. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The firm's 50-day moving average is $52.53 and its two-hundred day moving average is $49.60.

Analysts Set New Price Targets

Several research analysts have commented on the company. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. The Goldman Sachs Group began coverage on shares of Relx in a research report on Wednesday, March 26th. They issued a "buy" rating on the stock. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.